ciprofloxacin has been researched along with itraconazole in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cho, SJ; Park, KD | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ahmad, A; Khan, AU; Rauf, A; Rehan, M; Subbarao, N; Varshney, H | 1 |
| Al-Dhfyan, A; Al-Dosari, MS; Al-Omar, MA; Bhat, MA; Khan, AA; Khan, S; Parvez, MK | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| de'Clari, F | 1 |
| Brunet, J; Cancelas, JA; López-López, JJ; Maroto, P; Mendoza, L; Montesinos, J; Ojeda, B; Rodríguez, M; Salazar, R; Solá, C; Tabernero, JM; Valentí, V; Verger, G | 1 |
| Borlenghi, E; Capucci, MA; Carosi, GP; Cattaneo, C; Franco, F; Grazioli, L; Pan, A; Quaresmini, G; Rossi, G | 1 |
| Abou-Auda, HS; Al-Humayyd, MS; Mustafa, AA | 1 |
| Arechavala, AI; Bianchi, MH; González, G; Maiolo, E; Negroni, R; Orduna, T; Santiso, G | 1 |
| de Mol, P; Meis, JF | 1 |
| Mahatthanatrakul, W; Ridtitid, W; Samaeng, M; Sriwiriyajan, S; Wongnawa, M | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Dong, B; Hadinoto, K; Ming Lim, L; Yu, H | 1 |
3 review(s) available for ciprofloxacin and itraconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
1 trial(s) available for ciprofloxacin and itraconazole
| Article | Year |
|---|---|
Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Half-Life; Humans; Itraconazole; Male; Young Adult | 2011 |
20 other study(ies) available for ciprofloxacin and itraconazole
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
Topics: Anti-Infective Agents; Bacteria; Camellia sinensis; Catechin; Drug Design; Drug Stability; Fungi; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Structure; Tea | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Designing and synthesis of novel antimicrobial heterocyclic analogs of fatty acids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida; Cyclization; Dose-Response Relationship, Drug; Drug Design; Fatty Acids; Heterocyclic Compounds; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Software; Structure-Activity Relationship | 2013 |
Synthesis and anti-Candidal activity of N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl carbonyl) hydrazinecarbothioamide.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Hep G2 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Conformation; Pyridines; Thioamides | 2014 |
Ciprofloxacin was the culprit--not itraconazole.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bronchodilator Agents; Central Nervous System; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Theophylline; Time Factors | 1997 |
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ciprofloxacin; Combined Modality Therapy; Communicable Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Male; Middle Aged; Neoplasms; Prospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Transplantation, Autologous; Treatment Outcome | 1999 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxacin; Female; Humans; Itraconazole; Leukemia; Male; Middle Aged; Models, Theoretical; Ofloxacin; Practice Guidelines as Topic; Reproducibility of Results; Treatment Outcome | 2007 |
Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Half-Life; Itraconazole; Ketoconazole; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Time Factors | 2008 |
[Clinical cases in Medical Mycology. Case No. 29].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Infectious; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Debridement; Drainage; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunocompromised Host; Itraconazole; Lymphangitis; Male; Mycetoma; Psoas Abscess; Scedosporium; Staphylococcal Infections; Vancomycin | 2007 |
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2009 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Proof-of-concept preparation and characterization of dual-drug amorphous nanoparticle complex as fixed-dose combination of poorly soluble drugs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Carriers; Drug Combinations; Itraconazole; Nanoparticles; Proof of Concept Study; Solubility | 2019 |